Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes Mellitus, Type 2

In brief

This open label study is designed to assess long term glucose control, as measured by hemoglobin A1c (HbA1c) and to evaluate long term safety and tolerability in subjects with type 2 diabetes mellitus who receive subcutaneously injected exenatide administered twice a day.

Key facts

Study ID

NCT00111540

Run by

AstraZeneca

People needed

456

Starts

2002-11-01

Expected to finish

2006-09-01

Last updated by the study team

2015-02-23

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject has an HbA1c value <=11.0%
• The subject has a body mass index (BMI) of 25 kg/m\^2 to 45 kg/m\^2, inclusive

You may not qualify if…

• Is currently treated with certain medications, including exogenous insulin

Where it is running

• Research Site — Anaheim, California, United States
• Research Site — Bellflower, California, United States
• Research Site — Burlingame, California, United States
• Research Site — Chula Vista, California, United States
• Research Site — Concord, California, United States
• Research Site — Encino, California, United States
• Research Site — Fremont, California, United States
• Research Site — La Jolla, California, United States
• Research Site — Los Gatos, California, United States
• Research Site — Moreno Valley, California, United States
• Research Site — Redwood City, California, United States
• Research Site — San Mateo, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Aurora, Colorado, United States
• Research Site — Denver, Colorado, United States
• Research Site — Gainesville, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Largo, Florida, United States
• Research Site — Maitland, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Ocala, Florida, United States
• Research Site — Blairsville, Georgia, United States
• Research Site — Honolulu, Hawaii, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.